1 | Q53SV1 | Activin receptor, type I | ACVR1A /ALK-2 | 35.5 |
2 | P36896 | Activin receptor type-1B | ACVR1B / ALK-4 / Actin RIB / SKR2 | 15.4 |
3 | P27037 | Activin receptor type-2A | ACVR2A / Act R-Ⅱa | 1.4 |
4 | P37023 | Serine/threonine-protein kinase receptor R3 | ACVRL1 | 2.1 |
6 | P31749 | RAC-alpha serine/threonine-protein kinase | Akt1 / PKB alpha | 0.5 |
7 | P31751 | RAC-beta serine/threonine-protein kinase | Akt2 / PKB BETA | 9.2 |
8 | Q9Y243 | RAC-gamma serine/threonine-protein kinase | Akt3 / PKBG | 0.7 |
9 | Q13740 | Activated leukocyte cell adhesion molecule | ALCAM / CD166 | 0.2 |
10 | Q9H6B4 | Adipocyte-specific adhesion molecule | ASAM / CLMP / ACAM | 4.5 |
11 | P30530 | AXL receptor tyrosine kinase | Axl | 5.4 |
12 | Q96GW7 | Brevican core protein / Brain-enriched hyaluronan-binding protein | Bcan / Brevican / BEHAB | 21.1 |
13 | Q13873 | Bone morphogenetic protein receptor, type II | BMPR-2 | 10.3 |
14 | P07858 | Cathepsin B1/ APP secretase | Cathepsin B / APPS / CTSB / CPSB | 1.2 |
15 | P53634 | Dipeptidyl peptidase 1 | Cathepsin C / DPPI / Cathepsin J / CTSC / CPPI | 3.7 |
16 | P42702 | Leukemia inhibitory factor receptor alpha | CD118 / LIFR | 0.7 |
17 | P20701 | Integrin alpha L beta 2/Integrin alpha-L | CD11a / Integrin αLβ2 / LFA1 / INaLb2 | 1.3 |
18 | P11215 | Integrin alpha M beta 2 / CR-3 alpha chain/complement receptor type 3 | CD11b / Integrin αMβ2 / MAC1 / CR3 / INaMb2 | 2.4 |
19 | P01730 | CD4 antigen / T-cell surface antigen T4/Leu-3 | CD4 / L3T4 / T4 / (W3/25) | 13.4 |
20 | P09326 | CD48 antigen / B-lymphocyte activation marker BLAST-1 | CD48 / BCM1 / SLAMF2 / BLAST-1 | 42.0 |
21 | P19256 | Lymphocyte function-associated antigen 3 | CD58 / LFA3 | 14.8 |
22 | P60033 | CD81 antigen | CD81 (TAPA-1, TMSF) | 7.6 |
23 | Q9UIB8 | SLAM family member 5 | CD84 / SLAMF5 | 16.8 |
24 | P55287 | Cadherin 11, type 2, OB-cadherin | CDH11 | 14.6 |
25 | P55289 | Cadherin 12, type 2, N-cadherin 2 | CDH12 / CAD12 | 6.8 |
26 | P22223 | Cadherin 3, type 1, P-cadherin | CDH3 | 10.8 |
27 | P33151 | Cadherin 5, type 2, VE-cadherin | CDH5 / 7B4 | 5.8 |
28 | P55285 | Cadherin 6, type 2, K-cadherin | CDH6 / KCAD | 0.6 |
29 | P12830 | Cadherin 1, type 1, E-cadherin | CDHE / CDH1 | 0.2 |
30 | Q8N4D0 | Carcinoembryonic antigen-related cell adhesion molecule | CEACAM-5 / CEA / CD66e | 12.3 |
31 | O00533 | Cell adhesion molecule with homology to L1CAM2/KEGG # K06758 | CHL1 / CALL / L1-CAM2 | 0.7 |
32 | O95832 | Claudin1 | Claudin1 | 7.0 |
34 | P26992 | Ciliary neurotrophic factor receptor alpha | CNTFRA / CNTFR-alpha | 2.6 |
35 | Q8IWV2 | Contactin 4/KEGG # K06762 | CNTN4 / BIG-2 | 0.9 |
36 | O94779 | Contactin 5/KEGG # K06763 | CNTN5 / NB-2 | 0.4 |
37 | Q08345 | Epithelial discoidin domain-containing receptor 1 | DDR1 / CD167A | 4.1 |
38 | Q9NR61 | Delta-like protein 4 | DLL4 | 0.5 |
39 | Q15762 | DNAV accessory molecule-1 | DNAM1 / CD226 antigen | 91.2 |
40 | Q9UNE0 | Tumor necrosis factor receptor superfamily member EDAR | EDAR | 3.8 |
41 | P00533 | Epidermal growth factor receptor | EGFR / ErbB1 / HER-1 / ErbB | 0.6 |
42 | P60842 | Eukaryotic translation initiation factor-4A | EIF4A | 2.4 |
43 | Q05CQ1 | EIF5B protein | EIF5B | 3.4 |
44 | P17813 | Endoglin | Endoglin / CD105 / ENG | 60.6 |
45 | Q4G0R4 | Eph(Ephrin) receptor A10 | EphA10 | 0.1 |
46 | P29317 | Eph receptor A2 | EphA2 / Eck / Myk2 / Sek2 | 1.4 |
47 | P54760 | Eph receptor B4 | EphB4 / Myk1 / Tyto11 | 6.7 |
48 | O15197 | Eph(Ephrin) receptor B6 | EphB6 | 0.4 |
50 | Q96AP7 | Endothelial cell adhesion molecule | ESAM | 1.0 |
51 | P11362 | FGF R1alpha (Ⅲb) | FGFR1 alpha (Ⅲb) | 15.7 |
52 | P11362 | FGF R1α(IIIc) | FGFR1 alpha (IIIc) | 0.8 |
53 | P11362 | FGF R1beta (Ⅲb) | FGFR1 beta (Ⅲb) | 17.7 |
54 | P11362 | FGF R1beta (Ⅲc) | FGFR1 beta (Ⅲc) | 1.2 |
55 | Q0IJ44 | Fibroblast growth factor receptor 3b | FGFR3 beta | 0.3 |
56 | P22607 | Fibroblast growth factor receptor 3c | FGFR3 C | 0.8 |
57 | P22455 | Fibroblast growth factor receptor 4 | FGFR4 | 0.1 |
58 | P36888 | Fms-like tyrosine kinase 3 / Fetal liver kinase / Stem cell tyrosin kinase | FLT-3 / FLK-2 / Stk-1 | 0.5 |
59 | Q9UP38 | Frizzled-1 | Frizzled-1 / FzE1 / FZD1 | 6.4 |
60 | P10912 | Growth hormone receptor | GHR | 38.0 |
61 | P35052 | Glypican 1 | Glypican1 / GPC1 | 23.9 |
62 | Q8N158 | Glypican 2 | GPC2 | 0.9 |
63 | P51654 | Glypican 3 | GPC3 / OCI5 / GTR2-2 / MXR7 | 4.5 |
64 | P78333 | Glypican 5 | GPC5 | 0.3 |
65 | Q9Y625 | Glypican 6 | GPC6 | 3.6 |
66 | P14625 | GRP94 | GRP94 | 8.7 |
67 | P08581 | Hepatocyte growth factor receptor | HGFR / c-MET / MET | 0.4 |
68 | P09429 | High-mobility group box 1 | HMGB1 / HMG1 / Amphoterin | 0.1 |
69 | P07900 | Heat shock protein HSP 90-alpha / Heat shock 86 kDa | HSP90a / HSP 86 / HSP90AA1 / HSPC1 / HSPCA | 17.6 |
70 | P13598 | Intercellular adhesion molecule 2 | ICAM2 / CD102 | 1.2 |
71 | P32942 | Intercellular adhesion molecule 3 | ICAM3 / CD50 | 0.2 |
72 | Q9Y6W8 | Inducible T-cell co-stimulator | ICOS / AILIM / CD278 / CRP-1 | 18.7 |
73 | P38484 | Interferon gamma receptor 2 | IFN-gamma(γ) R2 / IFNGR2 | 3.1 |
74 | P08069 | Insulin-like growth factor 1 receptor | IGF1R / CD221 | 0.7 |
79 | Q8N126 | Immunoglobulin superfamily, member 4B / Cell adhesion molecule 3 | IGSF4B / NECL1 / TSLL1 / CADM3 / SynCAM-3 | 1.3 |
80 | Q13651 | Interleukin 10 receptor, alpha/KEGG # K05134 | IL10 R alpha / IL10R | 1.3 |
81 | Q99665 | Interleukin 12 receptor, beta 2 | IL12 R beta2 | 0.8 |
82 | Q14627 | Interleukin 13 receptor, alpha 2 | IL13 R alpha2 | 30.5 |
83 | Q96F46 | Interleukin-17 receptor A/KEGG # K05164 | IL17R / IL17RA / CD217 | 14.1 |
84 | Q8NAC3 | Interleukin 17 receptor C | IL17 R C / IL-17 RL / IL-17 Rhom | 14.1 |
85 | Q8NFM7 | Interleukin 17 receptor D/Similar expression to FGFs | IL17 R D / SEF | 0.0 |
86 | P27930 | Interleukin 1 receptor, type II | IL1 R2 / CD121b | 1.6 |
87 | Q9NP60 | Interleukin 1 receptor accessory protein-like | IL1 R APL2 / IL1R9 | 17.8 |
88 | Q5VWK5 | Interleukin 23 receptor | IL23 R | 0.1 |
89 | P01589 | Interleukin 2 receptor, alpha/ Tac antigen | IL2 R alpha / CD25 | 1.3 |
90 | P14784 | Interleukin 2 receptor, beta/KEGG # K05069 | IL2 R beta / CD122 | 7.8 |
91 | P31785 | Cytokine receptor common subunit gamma | IL2 R gamma | 4.3 |
92 | P26951 | Interleukin 3 receptor, alpha | IL3 R alpha / CD123 / IL3R | 71.4 |
93 | Q01344 | Interleukin 5 receptor, alpha/KEGG # K05067 | IL5 R alpha / CD125 / IL5R | 22.8 |
94 | P08887 | Interleukin-6 receptor subunit alpha | IL6 R / CD126 | 0.6 |
95 | P40189 | Interleukin-6 receptor subunit beta / Membrane glycoprotein 130 | IL6ST / gp130 / CD130 | 0.9 |
96 | P16871 | Interleukin 7 receptor alpha/KEGG # K05072 | IL7 R alpha / CD127 | 1.3 |
97 | Q01113 | Interleukin 9 soluble receptor | IL9 sR / CD129 | 5.2 |
98 | P06756 | Integrin alpha V beta 3 | Integrin αVβ3 / INaVb3 | 17.6 |
99 | P06756 | Integrin alpha V beta 6 | Integrin αVβ6 / INaVb6 | 29.6 |
100 | P06756 | Integrin alpha V beta 8 | Integrin αVβ8 / INaVb8 | 6.8 |
101 | - | Interferon receptor | Interferon receptor | 4.7 |
102 | P06213 | Insulin Receptor | IR / Insulin R / INSR / CD220 | 0.3 |
103 | Q9UEF7 | KLOTHO | Klotho / KL | 4.6 |
104 | Q99538 | Legumain | Legumain | 1.2 |
105 | P48357 | Leptin receptor | Leptin R / OB-R / B219 | 0.4 |
106 | Q803L0 | Protein lin-28 homolog A | hLin28 | 0.8 |
107 | Q6UXM1 | Leucine-rich repeats and immunoglobulin-like domains protein 3 | LRIG3 | 0.2 |
108 | O75581 | Low-density lipoprotein receptor-related protein-6 | LRP6 | 20.8 |
109 | P14151 | L-selectin / CD62 antigen-like family member L | L-Selectin / SELL / CD62L | 4.6 |
110 | Q12866 | c-mer proto-oncogene tyrosine kinase | MERTK / MER | 8.8 |
111 | P40238 | Myeloproliferative leukemia virus oncogene / Thrombopoietin receptor | MPL / CD110 / TpoR | 1.8 |
112 | P49959 | Double-strand break repair protein MRE11A | Mre11 & Rad50 | 0.2 |
113 | P13591 | Neural cell adhesion molecule-1 | NCAM-1 / CD56 | 2.1 |
114 | P08138 | Nerve growth factor receptor / p75 neurotrophin receptor | NGFR / TNFRSF16 | 17.8 |
115 | Q8N0W4 | Neuroligin-4, X-linked | NLGN4 / NL4 / NL4X / NLGN4X | 0.1 |
116 | P46531 | Neurogenic locus notch homolog protein 1 | Notch-1 | 3.6 |
117 | Q04721 | Neurogenic locus notch homolog protein 2 | Notch-2 | 0.4 |
118 | Q9UM47 | Neurogenic locus notch homolog protein 3 | Notch-3 | 2.4 |
119 | O14786 | Neuropilin 1 / Vascular endothelial cell growth factor 165 receptor | NRP1 / Npn-1 / Neuropilin 1 / CD304 | 1.8 |
120 | Q7LBX6 | Neuropilin 2 | NRP2 | 0.3 |
121 | Q14982 | Opioid-binding cell adhesion molecule / KEGG # K06773 | OPCML / OBCAM | 1.9 |
122 | Q9NZQ7 | Programmed cell death 1 ligand 1 / Human B7 homolog | PDL1 / PDCD1 LG 1 / CD274 / B7-H1 | 18.0 |
123 | Q9BQ51 | Programmed cell death 1 ligand 2 | PDCD1 LG 2 / PD-L2 | 4.9 |
124 | P09619 | Platelet-derived growth factor receptor, beta polypeptide | PDGFR beta | 3.5 |
125 | P16284 | Platelet endothelial cell adhesion molecule | PECAM1 / CD31 | 1.1 |
126 | Q9ULL4 | Plexin-B3 | Plexin B3 / PLXNB3 / KIAA1206 / PLXN6 | 5.6 |
127 | O60486 | Virus-encoded semaphorin protein receptor | Plexin C1 / PLXNC1 / VESPR / CD232 | 0.1 |
128 | P41743 | Protein kinase C iota type / Atypical protein kinase C-lambda/iota | PRKCI / GST-PKC-γ | 80.7 |
129 | P16471 | Prolactin receptor | PRL R | 3.7 |
130 | Q15109 | Receptor for advanced glycation endproducts | RAGE / AGER | 0.1 |
131 | P07949 | Proto-oncogene tyrosine-protein kinase receptor | RET | 1.2 |
132 | Q6ZVN8 | Hemojuvelin / Hemochromatosis type 2 protein | RGM-C / HFE2 / HJV | 0.2 |
133 | P61586 | Ras homolog gene family, member A | RhoA | 5.8 |
134 | Q9HCK4 | Roundabout homolog 2 | ROBO2 | 5.1 |
135 | Q96MS0 | Roundabout homolog 3 | ROBO3 | 0.5 |
136 | P10721 | Mast / stem cell growth factor receptor Kit | SCFR / c-kit / CD117 / KIT | 0.0 |
137 | P16109 | P-selectin | SELP / P-Selectin / GMP-140 / CD62P | 0.3 |
138 | Q6IA17 | Single Ig IL-1-related receptor/KEGG # K05169 | SIGIRR | 19.4 |
139 | Q96RL6 | Sialic acid binding Ig-like lectin 11/KEGG # K06750 | SIGLEC11 | 0.3 |
140 | Q08ET2 | Sialic acid binding Ig-like lectin 14 | SIGLEC14 | 5.7 |
141 | P20138 | Sialic acid binding Ig-like lectin 3/KEGG # K06473 | SIGLEC3 / CD33 / CD33 antigen | 1.9 |
142 | O15389 | Sialic acid binding Ig-like lectin 5/KEGG # K06549 | SIGLEC5 | 1.3 |
143 | O43699 | Sialic acid binding Ig-like lectin 6/KEGG # K06738 | SIGLEC6 | 0.1 |
144 | Q9Y336 | Sialic acid binding Ig-like lectin 9/KEGG # K06740 | SIGLEC9 | 0.2 |
145 | Q9HBG7 | T-lymphocyte surface antigen Ly-9 | SLAMF3 / CD229 / Ly9 | 6.2 |
146 | Q9P0V8 | SLAM family member 8 | SLAMF8 / BLAME | 9.1 |
147 | Q9BZZ2 | Sialoadhesin/Sialic acid-binding Ig-like lectin 1 | SN / Slglec-1 / CD169 | 2.7 |
148 | P63165 | Small ubiquitin-related modifier 1/GAP-modifying protein 1 | SUMO1 / SMT3C / SMT3H3 / UBL1 | 0.3 |
149 | P61956 | Small ubiquitin-related modifier 2 | SUMO2 | 11.0 |
150 | Q03167 | Transforming growth factor beta receptor type 3 | TGF beta R III | 79.3 |
151 | P35590 | Tyrosine kinase with immunoglobulin and EGF homology | TIE-1 / Tie | 10.1 |
152 | Q02763 | Tyrosine kinase with immunoglobulin and EGF homology | TIE-2 / TEK | 5.0 |
153 | O60603 | Toll-like receptor 2 | TLR2 / CD282 | 6.7 |
154 | Q6PCD4 | Toll-like receptor 3 | TLR3 / CD283 | 0.8 |
155 | O00206 | Toll-like receptor 4/ MD2 Complex | TLR4 / MD2 Complex | 4.0 |
156 | P20333 | Soluble Tumor Necrosis Factor Receptor I | TNF sRII | 1.0 |
157 | - | Tumor necrosis factor receptor | TNFR / TNF receptor | 4.3 |
158 | P19438 | Tumor necrosis factor receptor superfamily member 1A | TNFRI / CD120A / TNFRSF1A / TNFAR | 0.7 |
159 | O00220 | Tumor necrosis factor receptor superfamily member 10A | TNFR SF10A / TRAIL R1 | 0.1 |
160 | Q6FH58 | TNFRSF10B protein | TNFR SF10B / TRAIL R2 / DR5 | 2.2 |
161 | Q9Y6Q6 | Tumor necrosis factor receptor superfamily member 11A | TNFR SF11A / RANK / ODFR | 5.5 |
162 | O00300 | Tumor necrosis factor receptor superfamily member 11B | TNFR SF11B / OPG /OCIF | 0.1 |
163 | Q53F36 | Tumor necrosis factor receptor 13B variant | TNFR SF13B / CD267 / TACI | 6.6 |
164 | Q96RJ3 | Tumor necrosis factor receptor superfamily member 13C | TNFR SF13C / BAFFR | 23.7 |
165 | Q92956 | Tumor necrosis factor receptor superfamily member 14 | TNFR SF14 / HVEM | 8.9 |
166 | Q6PE46 | Tumor necrosis factor receptor superfamily, member 17 | TNFR SF17 / BCMA | 1.5 |
167 | Q9NS68 | Tumor necrosis factor receptor superfamily member 19 | TNFR SF19 / TROY / TRADE | 2.9 |
168 | Q969Z4 | Tumor necrosis factor receptor superfamily member 19L | TNFR SF19L / RELT | 2.2 |
169 | O75509 | Tumor necrosis factor receptor superfamily member 21 | TNFR SF21 / DR6 | 12.7 |
170 | Q93038 | Tumor necrosis factor receptor superfamily member 25 | TNFR SF25 / DR3 | 5.5 |
171 | P36941 | Tumor necrosis factor receptor superfamily member 3 | TNFR SF3 / TNF RⅢ | 2.4 |
172 | P43489 | Tumor necrosis factor receptor superfamily member 4 | TNFR SF4 / CD134 / OX40 | 1.3 |
173 | P25942 | Tumor necrosis factor receptor superfamily member 5 | TNFR SF5 / CD40 | 26.5 |
174 | Q5T9P3 | Tumor necrosis factor receptor superfamily member 6 | TNFR SF6 / FAS / APO-1 | 18.3 |
175 | P26842 | TNFR superfamily member 7 | TNFR SF6B / DcR3 / TR6 / M68 | 0.3 |
176 | P28908 | CD27 antigen / Tumor necrosis factor receptor superfamily member 7 | TNFR SF7 / CD27 | 6.8 |
177 | Q9UBN6 | Tumor necrosis factor receptor superfamily member 8 | TNFR SF8 / CD30 | 1.0 |
178 | Q9UBN6 | Tumor necrosis factor receptor superfamily member 10D | TRAIL R4 / CD264 / TNFRSF10D | 1.7 |
179 | P50591 | Tumor necrosis factor ligand superfamily member 10 | TRAIL / TNF SF 10 / CD253 | 19.5 |
180 | Q16620 | Neurotrophic tyrosine kinase, receptor, type 2 | TrkB / NTRK2 | 3.0 |
181 | Q96CY4 | Neurotrophic tyrosine kinase, receptor, type 3 | TrkC / NTRK3 | 2.4 |
182 | P09758 | Tumor Associated Calcium Signal Transducer 2 | TROP-2 / TACSTD2 | 1.2 |
183 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | TYRO3 | 48.4 |
184 | P62988 | Ubiquitin | Ubiquitin | 0.2 |
185 | P17948 | FMS-like tyrosine kinase 1 | VEGFR1 / FLT-1 | 0.1 |
186 | P35968 | vascular endothelial growth factor 2 | VEGFR2 / KDR / Flk-1 | 0.1 |
187 | P26006 | Integrin alpha 3 beta 1 | VLA-3 / FRP-2 / CD49c / INa3b1 | 1.6 |
188 | P08648 | Integrin alpha 5 beta 1 | VLA-5 / CD49e / INa5b1 | 1.5 |
189 | Q99986 | Vaccinia-related kinase | VRK1 | 5.3 |
190 | Q80WA3 | V-set and immunoglobulin domain containing 4 | VSIG4 / CRIg / Z39IG | 4.0 |
191 | Q9HAV5 | Tumor necrosis factor receptor superfamily member 27 | XEDAR | 0.2 |
192 | P07947 | Proto-oncogene tyrosine-protein kinase Yes / Proto-oncogene c-Yes | YES / GST-YES1 | 7.0 |
193 | Q92994 | Transcription factor IIIB 90 kDa subunit | BRF1 | 2.1 |
194 | P54284 | Voltage-dependent L-type calcium channel subunit beta-3 | CACNB3 / CACNLB3 | 0.7 |
195 | P28906 | Hematopoietic progenitor cell antigen CD34 | CD34 | 70.7 |
196 | P08962 | CD63 antigen | CD63 / MLA1 / TSPAN30 | 8.8 |
197 | P31997 | Carcinoembryonic antigen-related cell adhesion molecule 8 | CD66b / CEACAM8 | 3.5 |
198 | P30085 | UMP-CMP kinase / Cytidine monophosphate kinase | CMPK1 / CMK / CMPK | 1.8 |
199 | O43324 | Eukaryotic translation elongation factor 1 epsilon-1 | EEF1E1 / AIMP3 / P18 | 102.4 |
200 | P21860 | Receptor tyrosine-protein kinase erbB-3
| ErbB3 / Her3 | 0.3 |
201 | Q15303 | Receptor tyrosine-protein kinase erbB-4
| ErbB4 / Her4 | 5.6 |
202 | Q9H098 | Protein FAM107B | FAM107B | 1.7 |
203 | Q9NRJ2 | Putative uncharacterized protein GSN-AS1 | GSN-AS1 | 1.9 |
204 | Q86VZ4 | Low-density lipoprotein receptor-related protein 11 | LRP11 | 0.8 |
205 | Q14392 | Leucine-rich repeat-containing protein 32 | LRRC32 | 0.4 |
206 | Q86YL7 | Podoplanin | PDPN / GP36 | 85.7 |
207 | - | Poly-Ub WT Chains(2-7)(K63-linked) | Poly ubiquitin K63 | 0.4 |
208 | P08575 | Receptor-type tyrosine-protein phosphatase C | PTPRC / CD45 | 57.3 |
209 | Q495A1 | T-cell immunoreceptor with Ig and ITIM domains | TIGIT / VSIG9 / VSTM3 | 23.2 |
210 | O15205 | Ubiquitin-like protein FAT10 | Ubiquitin D / FAT10 | 0.6 |
211 | Q12860 | Contactin 1 / Glycoprotein gp135 / Neural cell surface protein F3 | CNTN1 / KEGG # K06759 | 109.3 |
212 | O00592 | Podocalyxin | PODXL / PCLP-1 / Gp200 | 3.7 |
213 | P35222 | Catenin beta-1 / Beta-catenin | CTNNB1 / CTNNB | 1.0 |
214 | P00533 | Epidermal growth factor receptor vIII | EGFR vIII | 2.23 |
215 | Q9NYA1 | Sphingosine kinase 1 | SPHK1 / SK1 / SPK1 | 0.09 |
216 | P09486 | Basement-membrane protein 40 | SPARC / BM-40 / ON | 8 |
217 | P05362 | Intercellular adhesion molecule 1 | ICAM-1 / CD54 | 6.42 |
218 | O60500 | Nephrin / Renal glomerulus-specific cell adhesion receptor | NPHS1 | 1.56 |
219 | P23909 | DNA mismatch repair protein mutS | E.coli Muts | 0.1 |
220 | P26662 | Core (Hepatitis C virus core protein) | HCV Core | 1.4 |
221 | Q99IB8 | E2(Hepatitis C virus genotype 2a (isolate JFH-1) (HCV)) | HCV E2 | 0.1 |
222 | Q3UAI3 | CD36/SR-B3 | Mouse CD36 / SR-B3 | 0.2 |
223 | Q6IR19 | Eph receptor A1/Ephrin | Mouse EphA1 / EPH / Esk | 52.4 |
224 | Q3US58 | Leptin receptor | Mouse Leptin R / Lepr / OB-R | 4.6 |
225 | O35444 | Receptor foe advanced glycation end products | Mouse RAGE | 0.1 |
226 | Q9EPQ1 | Toll-like receptor 1 | Mouse TLR1 / CD281 | 1.9 |
227 | Q9EPW9 | Toll-like receptor 6 | Mouse TLR6 / CD286 | 15.3 |
228 | Q80WA3 | V-set and immunoglobulin domain containing 4 | Mouse VSIG4 / CRIg / Z39IG | 0.9 |
229 | O55005 | Roundabout, axon guidance receptor, homolog 0 (1)/Drosophila | Rat ROBO1 / DUTT1 | 8.8 |
230 | Q9H9Z2 | Protein lin-28 homolog A | Zebrafish Lin28 | 0.4 |
231 | - | Zika virus nonstructural protein 1 (Suriname strain) | ZIKV NS1 | 2.27 |
232 | P03466 | Influenza A virus (Strain A/Puerto Rico/8/1934 H1N1) | Influenza A type NP | 0.36 |
233 | R9UM87 | Middle East respiratory syndrome-related coronavirus Nucleoprotein | MERS NP | 1.95 |
234 | A0A023UN44 | Middle East respiratory syndrome-related coronavirus Spike1 | MERS Spike1 | 4.38 |